Ligand Initiates Clinical Trial with the Selective Androgen Receptor Modulator LGD-4033, a Potential Treatment of Muscle and Bone Disorders June 17, 2009
Ligand Pharmaceuticals and The Rockefeller University Enter Settlement Agreement and Mutual Release February 12, 2009
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer's Disease February 9, 2009